Patents by Inventor Narendra Chirmule

Narendra Chirmule has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11340238
    Abstract: The present invention provides an in vitro method for detecting the presence of neutralizing antibodies against recombinant human insulin (rHI) in human serum. It also provides a kit for an in vitro method of detection of the presence of recombinant human insulin (rHI) neutralizing antibodies.
    Type: Grant
    Filed: October 15, 2016
    Date of Patent: May 24, 2022
    Assignee: BIOCON LIMITED
    Inventors: Abhishek Kulshrestha, Ravi Shankar Maurya, Sudeep Sabde, Pallavi Hajela, Pawan Kalani, Ramakrishnan Melarkode, Narendra Chirmule
  • Patent number: 10513556
    Abstract: The present disclosure provides compositions and methods relating to antibodies that specifically bind to human erythropoietin. The disclosure provides nucleic acids encoding such antibodies and methods of making and using such antibodies.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: December 24, 2019
    Assignee: Amgen Inc.
    Inventors: Daniel T. Mytych, Narendra Chirmule, Dohan K. Weeraratne
  • Publication number: 20180306814
    Abstract: The present invention provides an in vitro method for detecting the presence of neutralizing antibodies against recombinant human insulin (rHI) in human serum. It also provides a kit for an in vitro method of detection of the presence of recombinant human insulin (rHI) neutralizing antibodies.
    Type: Application
    Filed: October 15, 2016
    Publication date: October 25, 2018
    Inventors: Abhishek KULSHRESTHA, Ravi Shankar MAURYA, Sudeep SABDE, Pallavi HAJELA, Pawan KALANI, Ramakrishnan MELARKODE, Narendra CHIRMULE
  • Publication number: 20170015743
    Abstract: The present disclosure provides compositions and methods relating to antibodies that specifically bind to human erythropoietin. The disclosure provides nucleic acids encoding such antibodies and methods of making and using such antibodies.
    Type: Application
    Filed: August 4, 2016
    Publication date: January 19, 2017
    Inventors: Daniel T. Mytych, Narendra Chirmule, Dohan K. Weeraratne
  • Patent number: 9441039
    Abstract: The present disclosure provides compositions and methods relating to antibodies that specifically bind to human erythropoietin. The disclosure provides nucleic acids encoding such antibodies and methods of making and using such antibodies.
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: September 13, 2016
    Assignee: Amgen Inc.
    Inventors: Daniel T. Mytych, Narendra Chirmule, Dohan K. Weeraratne
  • Publication number: 20130295113
    Abstract: The present disclosure provides compositions and methods relating to antibodies that specifically bind to human erythropoietin. The disclosure provides nucleic acids encoding such antibodies and methods of making and using such antibodies.
    Type: Application
    Filed: May 7, 2013
    Publication date: November 7, 2013
    Inventors: Daniel T. Mytych, Narendra Chirmule, Dohan K. Weeraratne